|
Second COVID Booster Significantly Protected Nursing Home Residents
|
|
New research underscores the importance of making sure that the most vulnerable elderly stay up to date with COVID-19 vaccine recommendations. The nationwide study demonstrated that nursing home residents who received a recommended second booster had 73.9% protection against severe composite outcomes of SARS-CoV-2-associated hospitalization or death and 89.6% protection against death alone. Learn more about this study.
|
|
|
Kidney Injury, Failure Lower With DOACs Versus Vitamin K Antagonists
|
|
|
For years, a steady transition has occurred from prescribing vitamin K antagonists, such as warfarin, to direct oral anticoagulants (DOACs), often because of the lower risk of heavy bleeding and the decreased need for monitoring. Find out how a new study determined a third compelling reason for the move to DOACs: a lower risk of kidney injury and failure.
|
|
Bronchodilator Therapy Not Helpful for Long-Term Smoker Lung Function
|
|
|
Long-term smokers often have serious respiratory symptoms but without airflow obstruction. A new study questioned whether those patients should be treated with drugs used for chronic obstructive pulmonary disease. The authors found that inhaled dual bronchodilator therapy did not decrease respiratory symptoms in smokers with preserved lung function as assessed by spirometry. Learn more about this recent study.
|
|
|
Oral Tecovirimat Well-Tolerated by Monkeypox Patients
|
|
Patients with monkeypox usually have a painful rash, as well as more typical viral symptoms such as fever, chills, muscle aches, and respiratory symptoms. Find out why a new research letter suggested that oral tecovirimat is well tolerated by patients with monkeypox infection, with minimal adverse effects and relatively quick resolution of symptoms.
|
|
.jpg)
